Source: Purdue University
A compound shows unparalleled selectivity in inhibiting the adenylyl cyclase 1 (AC1), making it a potential target for treating pain and reducing the dependency on opioids for pain management.
Full story.
Share this post
Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email
